Safety, Tolerance and Pharmacokinetics Study of Compound Edaravone Injection
Clinical trial NCT04219865 · COMPLETED
Trial details
- NCT number
- NCT04219865
- Sponsor
- Nanjing Yoko Biomedical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-05
- Primary completion
- 2019-08-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.